Symptoms of Low Vitamin D: Causes and Treatment
Deficiency
Symptoms & causes
Vitamin D deficiency is one of the most common nutritional deficiencies globally β estimated to affect over 1 billion people β with well-established consequences for bone health (rickets in children, osteomalacia and osteoporosis in adults), immune function, and muscle strength; sun exposure is the primary source and supplementation is practical and inexpensive.
Vitamin D deficiency is a global epidemic driven primarily by inadequate sun exposure, not poor diet. While severe deficiency causes rickets in children and osteomalacia in adults, many people with moderate deficiency experience only vague fatigue or muscle aches. Supplementation with vitamin D3 is effective and safe, but dosing must account for body weight β a factor routinely ignored in standard advice.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Vitamin D β a fat-soluble secosteroid that functions as a prohormone. Two main forms: D2 (ergocalciferol β plant-derived) and D3 (cholecalciferol β animal-derived; also synthesized in human skin from 7-dehydrocholesterol via UVB radiation). Activation pathway: skin D3 β liver 25-hydroxylation β 25(OH)D (calcidiol; the serum measurement of vitamin D status) β kidney 1Ξ±-hydroxylation β 1,25(OH)2D (calcitriol; the active hormone, regulates calcium and phosphate absorption). RDA: 600 IU/day for adults 1β70 years; 800 IU/day for adults over 70. UL: 4,000 IU/day. Endocrine Society clinical practice guideline suggests higher doses for deficiency treatment (1,500β2,000 IU/day maintenance for adults at risk). Dietary sources are limited: fatty fish (salmon, mackerel, tuna β 450β600 IU per 3 oz); egg yolks (~44 IU per egg); beef liver (~42 IU per 3 oz); fortified foods (milk β typically 120 IU per 8 oz; OJ, cereals, plant milks β variable). Sun exposure: 15β30 minutes of midday sun on face, arms, and legs for lighter-skinned individuals generates approximately 10,000β25,000 IU of vitamin D3.
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- In children: rickets β failure of bone mineralization causing bowed legs, knock knees, frontal bossing, dental abnormalities, growth failure
- In adults: osteomalacia β bone pain (diffuse, often in lower back, hips, pelvis, thighs; worsened by pressure), muscle weakness (proximal myopathy), bone tenderness to palpation
- Fractures with minimal trauma
- Falls in older adults (muscle weakness component)
- In severe deficiency: hypocalcemia (with tetany, paresthesias, seizures)
- Many moderate-deficiency adults are asymptomatic or have only fatigue and musculoskeletal aches β non-specific symptoms that do not reliably predict vitamin D status
Don't wait
See a doctor if
- Bone pain, significant muscle weakness, history of stress fractures or osteoporosis, or symptoms of hypocalcemia (tingling, muscle spasms, seizures) require clinical evaluation with serum 25(OH)D measurement
- Adults over 50 with fall risk, people with malabsorption conditions, and exclusively breastfed infants (breast milk is low in vitamin D) should have vitamin D status assessed
Who is most likely to run low
Some people are more prone to falling short than others β including many people on a weight-loss journey who are simply eating less.
- Adults over 65 (reduced skin synthesis + reduced dietary intake + reduced outdoor activity + renal function decline)
- Dark-skinned individuals at high latitudes
- Obese individuals (BMI >30)
- People with fat malabsorption
- Breastfed infants without supplementation
- People with chronic kidney disease (require activated vitamin D, calcitriol, not standard D3)
- People with minimal sun exposure for any reason
- On GLP-1 therapy with major dietary restriction
What causes low Vitamin D β a fat-soluble secosteroid that functions as a prohormone. Two main forms: D2 (ergocalciferol β plant-derived) and D3 (cholecalciferol β animal-derived; also synthesized in human skin from 7-dehydrocholesterol via UVB radiation). Activation pathway: skin D3 β liver 25-hydroxylation β 25(OH)D (calcidiol; the serum measurement of vitamin D status) β kidney 1Ξ±-hydroxylation β 1,25(OH)2D (calcitriol; the active hormone, regulates calcium and phosphate absorption). RDA: 600 IU/day for adults 1β70 years; 800 IU/day for adults over 70. UL: 4,000 IU/day. Endocrine Society clinical practice guideline suggests higher doses for deficiency treatment (1,500β2,000 IU/day maintenance for adults at risk). Dietary sources are limited: fatty fish (salmon, mackerel, tuna β 450β600 IU per 3 oz); egg yolks (~44 IU per egg); beef liver (~42 IU per 3 oz); fortified foods (milk β typically 120 IU per 8 oz; OJ, cereals, plant milks β variable). Sun exposure: 15β30 minutes of midday sun on face, arms, and legs for lighter-skinned individuals generates approximately 10,000β25,000 IU of vitamin D3.
- Inadequate sun exposure β the primary cause globally: indoor occupation, living at high latitudes (above ~35Β°N in winter), dark skin (melanin reduces UVB penetration), cultural/religious full-body covering, sunscreen use (SPF 15 blocks ~93% of UVB), aging (older adults have ~25% less 7-dehydrocholesterol in skin)
- Inadequate dietary intake β vitamin D is one of the rarest vitamins in food
- Malabsorption β Crohn's disease, celiac disease, cystic fibrosis, liver disease, short bowel syndrome (vitamin D is fat-soluble, requires bile for absorption)
- Obesity β vitamin D is sequestered in adipose tissue; obese individuals need approximately 2β3Γ higher vitamin D doses to achieve the same serum levels as non-obese adults
- Chronic kidney disease β impaired 1Ξ±-hydroxylation (need activated calcitriol, not standard vitamin D)
- Medications: anti-epileptics (phenobarbital, phenytoin, carbamazepine β induce CYP enzymes, accelerate vitamin D catabolism); orlistat (fat absorption blocker β reduces vitamin D absorption)
- Exclusively breastfed infants (breast milk insufficient vitamin D)
How low levels are diagnosed
Serum 25-hydroxyvitamin D [25(OH)D] β the standard clinical measure; reflects combined skin synthesis and dietary intake over several weeks; deficiency < 20 ng/mL; insufficiency 20β29 ng/mL; adequate β₯ 30 ng/mL by Endocrine Society. Note: serum 1,25(OH)2D (active calcitriol) should NOT be used to assess vitamin D status β it is tightly regulated by PTH and remains normal or elevated even in deficiency until severely depleted; only 25(OH)D reflects actual stores. PTH (parathyroid hormone): elevated in vitamin D deficiency as the body attempts to maintain calcium; indirect marker.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Supplementation: vitamin D3 (cholecalciferol) is preferred over D2 β D3 is approximately 87% more potent at raising and maintaining serum 25(OH)D; typical maintenance doses: 1,500β2,000 IU/day for deficiency prevention in adults; deficiency treatment: Endocrine Society recommends 50,000 IU/week D2 or D3 for 8β12 weeks then maintenance. Obese adults: 2β3Γ higher doses (6,000β10,000 IU/day for treatment). Dietary: fortified milk, fatty fish, egg yolks β hard to meet 600β800 IU/day from diet alone without fortified foods. Sun: 15β30 minutes midday for lighter skin in summer; not practical for dark-skinned individuals at high latitudes in winter; vitamin D from skin synthesis does not cause toxicity (body regulates production). Toxicity: hypervitaminosis D from excessive supplementation (>10,000 IU/day long-term) causes hypercalcemia, hypercalciuria, calcification of soft tissues; dietary sources and sun do not cause toxicity.
How to keep levels up
Supplementation is the most practical strategy for at-risk groups: 1,500β2,000 IU/day D3 for adults with inadequate sun exposure; 2,000β6,000 IU/day for obese adults. Sensible sun exposure (without burning). Dietary: fortified milk, fatty fish, eggs. For breastfed infants: AAP recommends 400 IU/day vitamin D supplement from shortly after birth. For adults over 70: 800 IU/day per RDA, but Endocrine Society recommends higher for deficiency risk.
When to see a clinician
Bone pain, muscle weakness, osteoporosis, history of fractures, or lab finding of low 25(OH)D. People with chronic kidney disease need calcitriol (prescription activated vitamin D), not over-the-counter D3. Routine vitamin D screening in the general asymptomatic population is not currently recommended by the USPSTF (2021 review found insufficient evidence for screening to improve health outcomes in asymptomatic adults); testing is appropriate in at-risk individuals.
Why Vitamin D Deficiency Is Genuinely Epidemic β And Why Sun Exposure Explains Most of It
Vitamin D deficiency is not a fringe problem β it's estimated to affect roughly one billion people worldwide, and in the United States alone, about 24% of adults have serum levels below the deficiency threshold. This isn't primarily a dietary failure; it's a consequence of modern indoor life colliding with human biology.
Humans evolved to synthesize vitamin D when UVB radiation from the sun hits our skin. Food sources are vanishingly rare: fatty fish like salmon provides a few hundred IU per serving, egg yolks contribute about 44 IU each, and fortified milk adds roughly 120 IU per cup. You simply cannot eat your way to adequate vitamin D status without fortified foods or supplements.
The modern epidemic is driven by predictable factors: office jobs that keep us indoors during peak sun hours, high-SPF sunscreen that blocks approximately 93% of UVB radiation, and the simple geography of living above roughly 35Β°N latitude β a line running from Los Angeles through Atlanta β where UVB intensity is insufficient for vitamin D synthesis from approximately November through March. For people with darker skin, the problem compounds: melanin is protective against UV damage but substantially reduces vitamin D synthesis rate, meaning dark-skinned individuals at northern latitudes face a near-impossible task getting adequate vitamin D from sun alone for much of the year.
Bottom line
Vitamin D deficiency is an epidemic of indoor modern life and northern latitudes β the deficit is principally a sun exposure problem that dietary changes alone cannot reliably solve, making supplementation practical and important for most at-risk groups.
Rickets, Osteomalacia, and Osteoporosis: The Bone Consequences at Every Life Stage
The bone health evidence for vitamin D is the one area where its causal role is not debated. At every life stage, severe deficiency produces characteristic and preventable bone disease.
In children, the result is rickets β a failure of growth plate mineralization that causes bowed legs, frontal bossing of the skull, chest deformities known as rachitic rosary, and dental abnormalities. Rickets is most common in exclusively breastfed infants who aren't given vitamin D supplements, which is why the American Academy of Pediatrics recommends 400 IU daily from shortly after birth. In adults, the equivalent condition is osteomalacia: diffuse bone pain β often in the lower back, hips, and thighs β that worsens with pressure, plus proximal muscle weakness that can mimic fibromyalgia or depression before a 25(OH)D test reveals the true cause.
The osteoporosis connection works through parathyroid hormone. When vitamin D is low, calcium absorption from the gut plummets β from roughly 30β40% down to 10β15%. The body compensates by ramping up PTH, which drives osteoclast-mediated bone resorption to maintain blood calcium levels. Over time, this leaches mineral from bone. Combined calcium and vitamin D supplementation does reduce fracture risk in deficient, institutionalized older adults, but the USPSTF's 2022 review found insufficient evidence to recommend routine supplementation for fracture prevention in all community-dwelling postmenopausal women β a nuance that conflicts with common clinical practice but deserves acknowledgment.
Bottom line
Vitamin D's most established clinical role is bone health β rickets in children and osteomalacia in adults are direct consequences of deficiency; osteoporosis prevention benefit via supplementation is real but primarily in deficient and institutionalized older adults, not all community-dwelling postmenopausal women.
The Extraskeletal Claims: Immune Function, Cancer Prevention, Cardiovascular Health β What the Evidence Actually Shows
Walk into any health food store and you'll see vitamin D marketed for immunity, heart health, cancer prevention, and mood. The observational evidence is genuinely intriguing β vitamin D receptors sit on virtually all immune cells, and study after study finds lower vitamin D levels in people with more infections, autoimmune disease, and worse cardiovascular outcomes. But observational associations are not the same as causal proof.
The VITAL trial β a randomized, placebo-controlled study of 25,871 participants taking 2,000 IU of vitamin D3 daily for a median of five years β is the most rigorous test we have. Its primary results, published in the New England Journal of Medicine in 2019, found no significant reduction in cancer incidence or major cardiovascular events. That's the honest headline most supplement marketing omits.
However, VITAL did produce one clinically meaningful secondary finding: cancer mortality was approximately 25% lower in the vitamin D group, with the separation appearing after two years of supplementation. For COVID-19, observational studies showed associations between low vitamin D and severe outcomes, but the best-powered RCTs have not consistently shown supplementation reducing severity. For cardiovascular disease and depression, large meta-analyses mirror the pattern β observational signals exist, but RCTs in non-deficient populations have not confirmed benefit. The critical methodological issue is that most extraskeletal RCTs enrolled participants with adequate or borderline vitamin D levels; the benefit may exist primarily in those who are actually deficient.
Bottom line
Vitamin D's extraskeletal claims (immune, cancer, heart, mood) are supported by observational data but have not been consistently confirmed in large RCTs in non-deficient populations β the VITAL trial is the most rigorous test and found no benefit for primary CV or cancer incidence endpoints, though cancer mortality reduction is a promising secondary finding.
Supplementation Dosing: D3 vs. D2, Daily vs. Weekly, and the Obesity Dose Adjustment
When supplementation is needed β and for most at-risk adults, it is β the practical details matter. First, choose vitamin D3 (cholecalciferol) over D2 (ergocalciferol). A meta-analysis by Tripkovic and colleagues found D3 is approximately 87% more potent at raising and maintaining serum 25(OH)D levels.
For deficiency prevention in at-risk adults, the Endocrine Society recommends 1,500β2,000 IU daily β notably higher than the official RDA of 600β800 IU, which was set primarily for bone health in the general population. When treating documented deficiency, the standard protocol is 50,000 IU weekly of D2 or D3 for 8 to 12 weeks, followed by maintenance dosing. Daily dosing is preferable for maintenance; very large infrequent boluses above 300,000 IU are not recommended and have paradoxically been associated with increased fall risk in some studies.
The most systematically overlooked dosing factor is body weight. Vitamin D is fat-soluble and gets sequestered in adipose tissue. Obese individuals β BMI above 30 β need approximately two to three times the standard dose to achieve the same serum levels as normal-weight adults. During active deficiency treatment, this means 6,000β10,000 IU daily. A standard 1,000 IU supplement is likely insufficient for most people with obesity trying to correct deficiency. Toxicity, characterized by hypercalcemia and soft tissue calcification, generally requires long-term intake above 10,000 IU daily and does not occur from sun exposure.
Bottom line
Obese adults need 2β3Γ higher vitamin D doses to achieve the same serum levels as normal-weight adults β a standard 1,000 IU/day supplement is likely insufficient for most people with BMI > 30 seeking to correct deficiency.
Vitamin D and GLP-1 Therapy: Obesity, Weight Loss, and the Expected Shift in Vitamin D Status
For patients using GLP-1 medications like semaglutide or tirzepatide, vitamin D status deserves attention for a reason that has nothing to do with drug interactions β there are none β and everything to do with fat physiology.
Vitamin D stored in adipose tissue doesn't just sit there inertly. As patients lose significant fat mass β 15 to 20% of body weight is common on current GLP-1 therapies β that sequestered vitamin D is released into circulation. Serum 25(OH)D typically rises during substantial weight loss even without changing supplementation. This is biologically well-established, though the precise magnitude in GLP-1-treated populations is still being characterized.
The practical implications are straightforward: a baseline 25(OH)D test at GLP-1 initiation identifies deficiency that needs correction. Obese individuals starting therapy likely need higher initial doses to correct deficiency during active weight loss. As weight loss progresses, supplementation dosing may need downward adjustment. Additionally, reduced caloric intake on GLP-1 therapy means less dietary vitamin D, and adequate vitamin D supports muscle strength β relevant for patients who may also experience some lean mass loss. A maintenance dose of 1,000β2,000 IU of D3 daily is a reasonable precaution for most GLP-1 patients.
Bottom line
GLP-1-driven weight loss releases vitamin D sequestered in fat tissue, naturally improving vitamin D status β but baseline testing before starting therapy identifies deficiency that needs correction, and ongoing supplementation with 1,000β2,000 IU of D3 daily remains prudent for most patients.
What most pages leave out
The wellness industry oversells vitamin D as a universal health supplement for immunity, mood, cancer prevention, and heart health based largely on observational associations; the largest RCT (VITAL trial) did not confirm most of these benefits in the general population. The important nuances: (1) benefit is real for bone health and in deficient individuals; (2) the obesity dose requirement (2β3Γ standard) is systematically ignored by generic supplement dosing advice; (3) the USPSTF finding that community-dwelling postmenopausal women do not clearly benefit from supplementation for fracture prevention conflicts with common clinical practice and should be acknowledged.
We flag this so you can make an informed choice β not to scare you off.
βFrequently Asked Questions
Symptoms include bone pain, muscle weakness, and fatigue. In children, severe deficiency causes rickets with bowed legs and growth failure. In adults, osteomalacia produces diffuse bone pain and pseudofractures. Many people with moderate deficiency are asymptomatic or experience only vague musculoskeletal aches.
The official RDA is 600β800 IU daily for adults. The Endocrine Society recommends 1,500β2,000 IU daily for deficiency prevention in at-risk adults. Obese individuals need two to three times higher doses. For treating documented deficiency, a typical protocol is 50,000 IU weekly for 8 to 12 weeks followed by maintenance dosing.
Vitamin D3 (cholecalciferol) is approximately 87% more potent at raising and maintaining serum 25(OH)D levels than D2 (ergocalciferol), based on a meta-analysis by Tripkovic and colleagues. Choose D3 when possible.
Deficiency is defined as serum 25(OH)D below 20 ng/mL. Insufficiency is 20β29 ng/mL. The Endocrine Society considers 30 ng/mL and above as adequate, though exact thresholds are debated between expert bodies.
Observational studies show associations, but the large VITAL trial found no significant reduction in cancer incidence or major cardiovascular events with 2,000 IU of vitamin D3 daily. A secondary analysis did find reduced cancer mortality after two years of supplementation. Benefit may exist primarily in people who are actually deficient.
Yes. Vitamin D toxicity causes hypercalcemia and potential kidney damage, generally requiring long-term intake above 10,000 IU daily. The official upper limit is 4,000 IU daily. Sun exposure does not cause toxicity because the body regulates skin synthesis.
Yes. Adipose tissue sequesters vitamin D, and significant weight loss releases stored vitamin D into circulation. GLP-1-assisted weight loss typically improves serum 25(OH)D even without supplementation changes, though baseline testing and ongoing supplementation remain prudent.
The USPSTF does not recommend routine vitamin D screening in asymptomatic adults. Testing is appropriate for high-risk individuals, including those with dark skin at northern latitudes, obesity, malabsorption conditions, adults over 65, and exclusively breastfed infants.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
Symptoms of Low Vitamin C: Causes and Treatment
Vitamin C deficiency (scurvy) still occurs today, causing bleeding gums, fatigue, and poor wound healing. Learn the symptoms, causes, and evidence-based treatment.
Read moreSymptoms of Low Vitamin K2: Causes and Treatment
Vitamin K2 deficiency symptoms include easy bruising and bleeding. Learn who's at risk, how it differs from K1, and the critical warfarin interaction.
Read moreSymptoms of Low Vitamin B: Causes and Treatment
Vitamin B deficiency isn't one conditionβit's eight. Learn the distinct symptoms of B12, folate, B1, and B3 deficiency, who's at risk, and when to see a doctor.
Read moreSymptoms of Low Vitamin B2 (Riboflavin): Causes, Treatment, and Who Is at Risk
Riboflavin (B2) deficiency causes mouth sores, magenta tongue, and eye irritation. Learn who is at risk, how it's diagnosed, and how to treat it safely.
Read moreSymptoms of Low Vitamin B1 (Thiamine): Causes & Treatment
Thiamine deficiency can cause Wernicke encephalopathy, a medical emergency. Learn the symptoms of low vitamin B1, causes like alcohol use, and why IV treatment is critical.
Read moreSymptoms of Low Vitamin B3 (Niacin): Causes & Treatment
Niacin deficiency causes pellagraβthe 'four Ds': dermatitis, diarrhea, dementia, and death. Learn the symptoms, causes, and how treatment differs from high-dose niacin.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less β care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door β no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.